Changchun Kaimisi Pharmaceutical

Changchun Kaimisi Pharmaceutical Co., Ltd. is a pharmaceutical enterprise located in the High-tech Industrial Development Zone of Changchun, China. Founded in 2003, the company focuses on the research, development, and large-scale production of chemical drugs, particularly injectable formulations. Its core product line includes a variety of anti-infectives, such as cephalosporin antibiotics, as well as treatments for digestive and cardiovascular conditions. The company maintains advanced manufacturing facilities that adhere to national Good Manufacturing Practice (GMP) standards. Changchun Kaimisi serves the Chinese domestic market by providing essential generic medications like Pantoprazole Sodium and Cefuroxime Sodium. Through its commitment to quality and innovation in drug delivery, the company has established itself as a significant player in the regional pharmaceutical industry.